Live tape
Top 8, mentions 7d7,129SPCX1,375 mentions▲ +0.09GOOGL1,319 mentions▲ +0.05NVDA1,135 mentions▲ +0.09MSFT799 mentions▲ +0.04QQQ700 mentions▲ +0.08META636 mentions▲ +0.05SPY596 mentions▲ +0.06AMZN569 mentions▲ +0.07

Equity · Healthcare

CVM

AMEX

CEL-SCI Corporation

$2.29 +14.25% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 2, 2026
Price · Chart
51 sessions
$2.5 $1.0 13 Jul 2 Oct

The line runs $1.23 on 13 July through $2.29 on 2 October, on a scale from $1.0 to $2.5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 51 sessions, 13 Jul – 2 Oct 2026
Market cap $40.2M
Avg volume 4.0K

as of Oct 2, 2026

CVM insider trades

SEC Form 4

CVM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 4 December 2025.

Date Insider Type Shares Value
04 Dec 2025 KERSTEN GEERT R Chief Executive Officer Buy 8,389 $50K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
30 Sep 2025 TALOR EYAL Chief Scientific Officer Award 260 $2K
30 Sep 2025 KERSTEN GEERT R Chief Executive Officer Award 570 $5K
30 Sep 2025 PRICHEP PATRICIA B Chief Financial Officer Award 466 $4K

CVM reported financials

SEC EDGAR XBRL SEC EDGAR

CVM reported net income of −$25.4M for the fiscal year ended 30 Sep 2025.

Figure Reported Period
Net income −$25.4M 30 Sep 2025 fiscal year
Diluted EPS −$6.27 30 Sep 2025 fiscal year
Total assets $21.4M 30 Jun 2026 at period end
Total equity $11.0M 30 Jun 2026 at period end

CVM earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q3 2026 −$0.47 —
31 Mar 2026 Q2 2026 −$0.67 —
31 Dec 2025 Q1 2026 −$0.68 —
30 Sep 2025 FY 2025 −$6.27 —
30 Jun 2025 Q3 2025 −$1.36 —
31 Mar 2025 Q2 2025 −$2.33 —
31 Dec 2024 Q1 2025 −$3.25 —
30 Sep 2024 FY 2024 −$15.31 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CVM institutional holders

SEC Form 13F SEC EDGAR

2 of the 45 institutional funds we track reported a CVM position for the quarter ended 30 Jun 2026 — a combined $802K; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Added +1,495.0% shares 572,460 $595K
Citadel Advisors New position 198,500 $206K

CVM fails-to-deliver

SEC CNS data SEC

On 28 Aug 2026, 1,917 shares of CVM failed to deliver (about $3K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
28 Aug 2026 1,917 $3K 0.011%
27 Aug 2026 1,997 $3K 0.011%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings